Trial Profile
Phase II study of CX 717 in patients with mild to moderate Alzheimer's disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2010
Price :
$35
*
At a glance
- Drugs CX 717 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 08 Nov 2005 New trial record.